Hospital treatment, mortality and healthcare costs in relation to socioeconomic status among people with bipolar affective disorder

BJPsych Open

Volumn 2, Issue 1, 2016, Pages 10-17

  Pan, Yi Ju ^d   Yeh, Ling Ling ^a   Chen, Yu Chun ^b   Kuo, Kuei Hong ^b   Chang, Chin Kuo ^c  

^a ASIA UNIVERSITY   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84988497751     PISSN: None     EISSN: 20564724     Source Type: Journal    
DOI: 10.1192/bjpo.bp.115.000810     Document Type: Article

References (40)

1. Tsuchiya KJ, Agerbo E, Byrne M, Mortensen PB. Higher socio-economic status of parents may increase risk for bipolar disorder in the offspring. Psychol Med 2004; 34: 787-93.
2. Schoeyen HK, Birkenaes AB, Vaaler AE, Auestad BH, Malt UF, Andreassen OA, et al. Bipolar disorder patients have similar levels of education but lower socioeconomic status than the general population. J Affect Disord 2011; 129: 68-74.
3. Keck PE Jr, McElroy SL, Strakowski SM, West SA, Sax KW, Hawkins JM, et al. 12-month outcome of patients with bipolar disorder following hospitalization for a manic or mixed episode. Am J Psychiatry 1998; 155: 646-52.
4. Craig TJ, Grossman S, Mojtabai R, Gibson PJ, Lavelle J, Carlson GA, et al. Medication use patterns and 2-year outcome in first-admission bipolar disorder with psychotic features. Bipolar Disord 2004; 6: 406-15.
5. Tse S, Chan S, Ng KL, Yatham LN. Meta-analysis of predictors of favorable employment outcomes among individuals with bipolar disorder. Bipolar Disord 2014; 16: 217-29.
6. Perlick DA, Rosenheck RA, Clarkin JF, Sirey J, Raue P. Symptoms predicting inpatient service use among patients with bipolar affective disorder. Psychiatr Serv 1999; 50: 806-12.
7. Carlson GA, Kotov R, Chang SW, Ruggero C, Bromet EJ. Early determinants of four-year clinical outcomes in bipolar disorder with psychosis. Bipolar Disord 2012; 14: 19-30.
8. Hoang U, Stewart R, Goldacre MJ. Mortality after hospital discharge for people with schizophrenia or bipolar disorder: retrospective study of linked English hospital episode statistics, 1999-2006. BMJ 2011; 343: d5422.
9. Wahlbeck K, Westman J, Nordentoft M, Gissler M, Laursen TM. Outcomes of Nordic mental health systems: life expectancy of patients with mental disorders. Br J Psychiatry 2011; 199: 453-8.
10. Lawrence D, Hancock KJ, Kisely S. The gap in life expectancy from preventable physical illness in psychiatric patients in Western Australia: retrospective analysis of population based registers. BMJ 2013; 346: f2539.
11. Stringhini S, Dugravot A, Shipley M, Goldberg M, Zins M, Kivimaki M, et al. Health behaviours, socioeconomic status, and mortality: further analyses of the British Whitehall II and the French GAZEL prospective cohorts. PLoS Med 2011; 8: e1000419.
12. Woods SW. The economic burden of bipolar disease. J Clin Psychiatry 2000; 61 (suppl 13): 38-41.
13. Bebbington P, Ramana R. The epidemiology of bipolar affective disorder. Soc Psychiatry Psychiatr Epidemiol 1995; 30: 279-92.
14. Martin JL, McLean G, Park J, Martin DJ, Connolly M, Mercer SW, et al. Impact of socioeconomic deprivation on rate and cause of death in severe mental illness. BMC Psychiatry 2014; 14: 261.
15. National Health Insurance Administration. Enrollment and Underwriting [in Chinese]. NHI, 2014 (http://www.nhi.gov.tw/Resource/webdata/Attach_14258_2_97%E6%89%BF%E4%BF%9D-ch.pdf).
16. World Economic Outlook (WEO) data, IMF. Implied PPP (Purchasing Power Parity) Conversion Rate. ECONSTATS, 2014 (http://www.econstats.com/weo/V013.htm).
17. Liu CY, Hung YT, Chuang YL, Chen YJ, Weng WS, Liu JS, et al. Incorporating development stratification of Taiwan townships into sampling design of large scale health interview survey. J Health Manage 2006; 4: 1-22.
18. McCullagh P, Nelder J. Generalized Linear Models. Chapman and Hall, 1989.
19. Desai PR, Lawson KA, Barner JC, Rascati KL. Identifying patient characteristics associated with high schizophrenia-related direct medical costs in community-dwelling patients. J Manag Care Pharm 2013; 19: 468-77.
20. Wu CY, Chen YJ, Ho HJ, Hsu YC, Kuo KN, Wu MS, et al. Association between nucleoside analogues and risk of hepatitis B virus-related hepatocellular carcinoma recurrence following liver resection. JAMA 2012; 308: 1906-14.
21. Chang CK, Hayes RD, Broadbent M, Fernandes AC, Lee W, Hotopf M, et al. All-cause mortality among people with serious mental illness (SMI), substance use disorders, and depressive disorders in southeast London: a cohort study. BMC Psychiatry 2010; 10: 77.
22. World Health Organization. The World Health Report - Mental Health: New Understanding, New Hope. WHO, 2014 (http://www.who.int/whr/2001/en/).
23. Fleck DE, Keck PE Jr, Corey KB, Strakowski SM. Factors associated with medication adherence in African American and white patients with bipolar disorder. J Clin Psychiatry 2005; 66: 646-52.
24. Johnson FR, Ozdemir S, Manjunath R, Hauber AB, Burch SP, Thompson TR. Factors that affect adherence to bipolar disorder treatments: a stated-preference approach. Med Care 2007; 45: 545-52.
25. Macintyre S. The social patterning of exercise behaviours: the role of personal and local resources. Br J Sports Med 2000; 34: 6.
26. Laaksonen M, Prattala R, Helasoja V, Uutela A, Lahelma E. Income and health behaviours. Evidence from monitoring surveys among Finnish adults. J Epidemiol Community Health 2003; 57: 711-7.
27. Khaw KT, Wareham N, Bingham S, Welch A, Luben R, Day N. Combined impact of health behaviours and mortality in men and women: the EPIC-Norfolk prospective population study. PLoS Med 2008; 5: e12.
28. Byberg L, Melhus H, Gedeborg R, Sundstrom J, Ahlbom A, Zethelius B, et al. Total mortality after changes in leisure time physical activity in 50 year old men: 35 year follow-up of population based cohort. BMJ 2009; 338: b688.
29. Violan C, Foguet-Boreu Q, Roso-Llorach A, Rodriguez-Blanco T, Pons-Vigues M, Pujol-Ribera E, et al. Burden of multimorbidity, socioeconomic status and use of health services across stages of life in urban areas: a cross-sectional study. BMC Public Health 2014; 14: 530.
30. Bauer M, Glenn T, Rasgon N, Marsh W, Sagduyu K, Munoz R, et al. Association between median family income and self-reported mood symptoms in bipolar disorder. Compr Psychiatry 2011; 52: 17-25.
31. Eid L, Heim K, Doucette S, McCloskey S, Duffy A, Grof P. Bipolar disorder and socioeconomic status: what is the nature of this relationship? Int J Bipolar Disord 2013; 1: 9.
32. Calabrese JR, Fatemi SH, Kujawa M, Woyshville MJ. Predictors of response to mood stabilizers. J Clin Psychopharmacol 1996; 16: 24S-31S.
33. Bowden CL. Clinical correlates of therapeutic response in bipolar disorder. J Affect Disord 2001; 67: 257-65.
34. Ruzickova M, Turecki G, Alda M. Pharmacogenetics and mood stabilization in bipolar disorder. Am J Med Genet C Semin Med Genet 2003; 123C: 18-25.
35. Duffy A, Alda M, Kutcher S, Cavazzoni P, Robertson C, Grof E, et al. A prospective study of the offspring of bipolar parents responsive and nonresponsive to lithium treatment. J Clin Psychiatry 2002; 63: 1171-8.
36. Schou M, Thomsen K. Lithium prophylaxis of recurrent endogenous affective disorders. In Lithium Research and Therapy (FN Johnson): 3-85. Academic Press, 1975.
37. Bowden CL, Calabrese JR, McElroy SL, Gyulai L, Wassef A, Petty F, et al. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group. Arch Gen Psychiatry 2000; 57: 481-9.
38. Garnham J, Munro A, Slaney C, Macdougall M, Passmore M, Duffy A, et al Prophylactic treatment response in bipolar disorder: results of a naturalistic observation study. J Affect Disord 2007; 104: 185-90.
39. Hirschfeld RM, Cross CK. Epidemiology of affective disorders. Arch Gen Psychiatry 1982; 39: 35-46.
40. Berk M, Berk L, Castle D. A collaborative approach to the treatment alliance in bipolar disorder. Bipolar Disord 2004; 6: 504-18.